Incyte Corp. (INCY)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Incyte Corp. (INCY)
Go deeper and ask any question about INCY
Company Performance
Current Price
as of Sep 18, 2024$65.17
P/E Ratio
183.63
Market Cap
$12.55B
Description
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded in April 1991 and is headquartered in Wilmington, DE.
Metrics
Overview
- HQWilmington, DE
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerINCY
- Price$65.17-1.90%
Trading Information
- Market Cap$12.55B
- Float98.79%
- Average Daily Volume (1m)1,863,800
- Average Daily Volume (3m)2,310,638
- EPS$0.38
Company
- Revenue$3.86B
- Rev Growth (1yr)9.34%
- Net Income-$444.60M
- Gross Margin91.09%
- EBITDA Margin-43.61%
- EBITDA-$455.19M
- EV$11.74B
- EV/Revenue3.04
- P/E183.63
- P/S3.69
Documents
SEC Filings
Earnings Calls
Factset Street Account